Table 4.

Results of collaborative study for lethal toxicity and minimal hemorrhagic dose (MHD)

Test	Lethal toxicity (μg)||				Minimal hemorrhagic dose (MHD) (μg)||
	1*	2†	3‡	4§	1*	2†	3‡	4§
1	28.28	28.28	28.28	27.32	0.64	1.11	0.64	0.29
2	25.94	25.94	28.28	28.28	1.48	1.90	0.48	0.45
3	28.28	28.28	28.28	28.30	0.82	0.91	0.79	0.39
Common potency	27.50	27.50	28.28	27.97	0.98	1.31	0.64	0.38
95% confidence interval	25.97	25.97	-	27.33	0.48	0.71	0.46	0.28
	~29.03	~29.03		~28.60	~1.48	~1.90	~0.81	~0.47
Coefficients of variation (%)	4.92	4.91	-	2.00	44.72	40.33	24.21	21.48

^*National Institute of Food and Drug Safety Evaluation (NIFDS), Cheongju, Korea.

^†Osong Medical Innovation Foundation (KBIO), Cheongju, Korea.

^‡Koreavaccine co., Ansan, Korea.

^§National Institute of Infectious Diseases (NIID), Tokyo, Japan.

^||Titers are expressed as μg per animal.